Author:
Matsumura Noriomi,Mandai Masaki
Publisher
Springer Science and Business Media LLC
Reference4 articles.
1. Pharmaceuticals and Medical Devices Agency (2024) List of approved drugs (in Japanese). https://www.pmda.go.jp/files/000270227.pdf. Accessed 31 Aug 2024
2. Wu YL, Dziadziuszko R, Ahn JS et al (2024) Alectinib in resected ALK-positive non-small-cell lung cancer. N Engl J Med 390:1265–1276. https://doi.org/10.1056/NEJMoa2310532
3. Wakelee H, Liberman M, Kato T et al (2023) Perioperative pembrolizumab for early-stage non-small-cell lung cancer. N Engl J Med 389:491–503. https://doi.org/10.1056/NEJMoa2302983
4. Pharmaceuticals and Medical Devices Agency (2024) Revisions of PRECAUTIONS (FY2024). https://www.pmda.go.jp/english/safety/info-services/drugs/revision-of-precautions/0012.html. Accessed 31 Aug 2024